Skip to content

Clinical trials

Completed Lung Neoplasms trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Completed Country / region: Hong Kong Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20072
20081
20091
20112
20121
20133
20151
20163
20173
20181
20191
20203
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong3
Novartis Pharmaceuticals3
The University of Hong Kong3
Arcus Biosciences, Inc.2
Sanofi2
AVEO Pharmaceuticals, Inc.1
Ariad Pharmaceuticals1
AstraZeneca1
Boehringer Ingelheim1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms28
Carcinoma, Non-Small-Cell Lung16
Carcinoma4
Adenocarcinoma of Lung3
Neoplasms3
Adenocarcinoma2
Colorectal Neoplasms2
Lung Diseases2
Neoplasms by Histologic Type2
Neoplasms by Site2

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.